Provided by Tiger Trade Technology Pte. Ltd.

Fortrea Holdings Inc.

20.00
+0.60003.09%
Post-market: 20.000.00000.00%19:30 EDT
Volume:1.19M
Turnover:23.58M
Market Cap:1.90B
PE:-21.85
High:20.05
Open:19.58
Low:19.09
Close:19.40
52wk High:21.39
52wk Low:8.55
Shares:95.10M
Float Shares:94.23M
Volume Ratio:0.86
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9151
EPS(LYR):-10.8136
ROE:-15.30%
ROA:0.58%
PB:3.63
PE(LYR):-1.85

Loading ...

Fortrea Names Carrie Russell Chief Accounting Officer

Reuters
·
Oct 01

Fortrea Holdings Price Target Announced at $22.00/Share by UBS

Dow Jones
·
Sep 30

US Research Roundup-Acuity, Dell Technologies, Nike

Reuters
·
Sep 29

Fortrea Holdings Inc : Baird Raises Target Price to $24 from $23

THOMSON REUTERS
·
Sep 29

Arsenal-Backed Endpoint Clinical Acquires Clinical Supply Planning Firm Bluefin

Reuters
·
Sep 15

Fortrea Grants CFO Jason Knoblauch 106,755 PSUs and 144,434 RSUs as Inducement Awards

Reuters
·
Sep 11

Fortrea Announces Grant of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 11

Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Immunome (IMNM)

TIPRANKS
·
Sep 10

Fortrea CEO, CFO to Join Baird Global Healthcare Conference Fireside Chat

Reuters
·
Sep 10

Fortrea Reinstates Knoblauch as CFO After Legal Dispute with Former Employer

Dow Jones
·
Sep 10

Fortrea - Reinstates Jason Knoblauch as CFO on September 9, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 10

Fortrea - David Smith Steps Down as Interim CFO, Remains Board Member - SEC Filing

THOMSON REUTERS
·
Sep 10

Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)

TIPRANKS
·
Sep 03

U.S. Stocks on the MOVE-FuelCell, Gold Miners, NetApp

Reuters
·
Sep 03

Fortrea to Buy Worldwide Clinical Trials Early-Phase Services Unit for $45M All-Cash

Reuters
·
Sep 02

Fortrea - Early Phase Services to Join Fortrea's Clinical Pharmacology Services Business Unit

THOMSON REUTERS
·
Sep 02

Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials

THOMSON REUTERS
·
Sep 02

Fortrea - to Buy Early Phase Services Business in All-Cash Deal Valued at $45 Mln

THOMSON REUTERS
·
Sep 02

Fortrea Interim CAO Carrie Elizabeth Russell Files Initial Beneficial Ownership Statement

Reuters
·
Aug 18

Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV ADR (AGMB) and Sana Biotechnology (SANA)

TIPRANKS
·
Aug 17